4 unknown. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Unknown 4 |
Follow Pneumococcal Infections: new trials by email Literature Review of Pneumococcal Infections trials Research Report on Pneumococcal Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Concomitant Administration of the Novavax Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Adults Aged ≥60 Years NVX, PCV20, Placebo - COVID-19, Pneumococcal Infections | Phase 4 | Unknown | Medical University of Vienna | 256 | 2023-03-01 | 2023-03-15 |
| Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4 COVAX+PPV23;COVAX+IIV4, COVAX only (1st and 2nd dose), PPV23 for the 1st dose and IIV4 for the 2nd dose - Influenza, Human, Pneumonia, Pneumococcal | Phase 4 | Unknown | China National Biotec Group Company Limited | 1404 | 2021-05-06 | 2021-10-15 |
| Immunogenicity After Revaccination With 23-valent Pneumococcal Polysaccharide Vaccine: Healthy Elderly People Versus Diabetic Patients ProDiax-23 (PPSV23) - Pneumococcal Infections | Phase 4 | Unknown | Korea University Guro Hospital | 254 | 2021-05-01 | 2021-05-06 |
| PCV10 Reactogenicity and Immunogenicity Study - Malindi PCV10 and DTaP, hepatitis A vaccine, DTaP, PCV10 - Pneumococcal Pneumonia | Phase 4 | Unknown | KEMRI-Wellcome Trust Collaborative Research Program | 600 | 2010-01-01 | 2018-02-23 |
Pneumonia, Pneumococcal (2) · COVID-19 (1) · Diabetes Mellitus (1) · Influenza, Human (1)
Bacterial Infections (4) · Bacterial Infections and Mycoses (4) · Gram-Positive Bacterial Infections (4) · Infections (4) · Streptococcal Infections (4) · Lung Diseases (3) · Pneumonia (3) · Respiratory Tract Diseases (3) · Respiratory Tract Infections (3) · Pneumonia, Bacterial (2) · RNA Virus Infections (2) · Virus Diseases (2) · Coronaviridae Infections (1) · Coronavirus Infections (1)
10-valent pneumococcal conjugate vaccine (1) · 23-valent pneumococcal capsular polysaccharide vaccine (1) · Hepatitis A Vaccines (1) · PHiD-CV vaccine (1)
China National Biotec Group Company Limited (1) · KEMRI-Wellcome Trust Collaborative Research Program (1) · Korea University Guro Hospital (1) · Medical University of Vienna (1)
China (1) · Kenya (1) · South Korea (1)
Joon Young Song, MD, PhD. (1) · Laura Hammitt, MD (1)